100%
1/1 resolved calls right
1 scored · avg 70
single source
0
companies · 1 data points
23andMe will not be profitable at the $99 price point when they relaunch their product due to the costs of regulation.
What happened: 23andMe has never achieved profitability at its $99 price point; the company has continued to report losses, and regulatory costs have contributed to these financial outcomes.
Verify at source ↗